{
    "Trade/Device Name(s)": [
        "Stratus\u00ae CS Acute Care\u2122M NT-proBNP (pBNP) TestPak"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K071834",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043476",
        "K060548"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBC"
    ],
    "Summary Letter Date": "August 17, 2007",
    "Summary Letter Received Date": "July 3, 2007",
    "Submission Date": "June 30, 2007",
    "Regulation Number(s)": [
        "21CFR862.1117"
    ],
    "Regulation Name(s)": [
        "B-type Natriuretic Peptide Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "cardiac",
        "POCT"
    ],
    "Analyte(s)": [
        "N-terminal pro-brain natriuretic peptide (NT-proBNP)"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube (lithium or sodium heparin)"
    ],
    "Instrument(s)/Platform(s)": [
        "Stratus\u00ae CS Stat Fluorometric Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorometric immunoassay",
        "Radial Partition Immunoassay (RPIA)"
    ],
    "Methodologies": [
        "Two-site sandwich immunoassay",
        "Front surface fluorescence detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "TestPak"
    ],
    "Document Summary": "FDA 510(k) summary for Stratus\u00ae CS Acute Care NT-proBNP TestPak, a fluorometric immunoassay for quantitative NT-proBNP measurement in plasma using Stratus\u00ae CS Stat Fluorometric Analyzer",
    "Indications for Use Summary": "Quantitative measurement of NT-proBNP in human plasma as an aid in diagnosis, severity assessment of suspected congestive heart failure, and risk stratification in patients with acute coronary syndrome and heart failure, for clinical laboratory and point of care use",
    "fda_folder": "Clinical Chemistry"
}